✦ LIBER ✦

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

✍ Scribed by Sophie Leboulleux; Lars Bastholt; Thomas Krause; Christelle de la Fouchardiere; Jan Tennvall; Ahmad Awada; José Manuel Gómez; Françoise Bonichon; Laurence Leenhardt; Christine Soufflet; Muriel Licour; Martin J Schlumberger

Book ID: 119608973
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 324 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70335-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib in radioactive iodine-refracto

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

✍ Brose, Marcia S; Nutting, Christopher M; Jarzab, Barbara; Elisei, Rossella; Sien 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 367 KB

TAS-102 monotherapy for pretreated metas

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

✍ Takayuki Yoshino; Nobuyuki Mizunuma; Kentaro Yamazaki; Tomohiro Nishina; Yoshito 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 286 KB

Gefitinib versus placebo as maintenance

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

✍ Li Zhang; Shenglin Ma; Xiangqun Song; Baohui Han; Ying Cheng; Cheng Huang; Shuju 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 371 KB

Docetaxel and dasatinib or placebo in me

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

✍ Araujo, John C; Trudel, Géralyn C; Saad, Fred; Armstrong, Andrew J; Yu, Evan Y; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 703 KB

Randomized double-blind phase 2 trial of

Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer

✍ Aman Buzdar; Charles Vogel; Lee Schwartzberg; August Garin; Alejandra Perez; Jam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Gemcitabine-based or capecitabine-based

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

✍ Mukherjee, Somnath; Hurt, Christopher N; Bridgewater, John; Falk, Stephen; Cummi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 304 KB